About: FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.91 (-4.07%)
FBLG NASDAQ FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. Common Stock share price
Atividade de preço de FBLG
Último preço
$ 0,910
Variação (24h)
-0,04 USD (4,07%)
Volume
137.78K
Volume (média 4 sem.)
-
Abertura
$ 0,93
Variação do dia
$ 0,89 - $ 0,95
Fechamento anterior
$ 0,95
Último negócio
26 Oct, 5:24 pm GMT+0
Atrasado
26 Oct, 5:24 pm GMT+0
FBLG price performance
Atrasado
26 Oct, 5:24 pm GMT+0
quote.marketSignals